lecture fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Lifescan, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche Diabetes Care, and Sanofi
Peptides such as BPC-157, TB-500, and GHK-Cu are not FDA-approved for human therapy and are available for research use only
The peptides specifically scheduled for review at the 2026 meeting include: BPC-157 free base BPC-157 acetate KPV (lysine-proline-valine tripeptide) TB-500 (thymosin beta-4 fragment) MOTS-c (mitochondrial-derived peptide) The committee will vote on whether each listed substance meets the statutory criteria under Section 503A(b)(1)(A)(i)(III) of the Federal Food, Drug, and Cosmetic Act for inclusion on the bulk drug substances list used in compounding
10.9734/jpri/2021/v33i34b31853 150 WangC.XieL.XingY.LiuM.YangJ.GaoN.et al (2023)
Recently, ferroptosis, a prominent example of oxidative cell death, has garnered significant attention within the scientific community